FDA-cleared profile

EFAI Intelligent Cardiothoracic Ratio (iCTR) Assessment System

Ever Fortune. AI Co., Ltd. · X-ray/Radiography · FDA-cleared (510(k))

Authorized purpose: Automatic cardiothoracic-ratio assessment on PA chest X-ray images for adults 20-80 years old in healthcare institutions; results support clinician assessment and are not for standalone clinical decision-making.

Clinical role
Automated PA chest-radiograph quality control, heart and thoracic-cavity diameter annotation, CTR measurement, structured reporting, and non-predictive longitudinal CTR tracking for clinician review.
Images and patients
X-ray/Radiography · Heart and thoracic cavity for cardiothoracic-ratio measurement
Key limitation
Keep in mind: The output is not intended for standalone clinical decision-making and does not preclude clinical assessment. The labeled input is a PA chest X-ray for adults 20-80 years old; non-chest, non-PA, and unclear-boundary images are subject to quality-control filtering or messaging. The CTR trajectory does not implement a predictive or prognostic feature, and the packet does not establish a specific PACS, RIS, EHR, or current hosting configuration.

Overview status: Source-reviewed overview

Report a correction
Clinical details Purpose, workflow fit, evidence, and safety record

Workflow navigation pilot

Workflow role has not yet been reviewed for this navigation pilot.

A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources

  • What does this software do?Authorized purpose: Automatic cardiothoracic-ratio assessment on PA chest X-ray images for adults 20-80 years old in healthcare institutions; results support clinician assessment and are not for standalone clinical decision-making.
  • Which images or clinical context are in scope?Modality: X-ray/Radiography Anatomy or clinical context: Heart and thoracic cavity for cardiothoracic-ratio measurement Input: DICOM chest X-ray images in posterior-anterior (PA) view from adults 20-80 years old; quality-control models filter non-chest and non-PA images and present a message for images with unclear boundaries below the stated threshold.
  • Who uses it?Intended users: Physicians or other licensed practitioners in healthcare institutions such as clinics, hospitals, healthcare facilities, residential care facilities, and long-term care services
  • What does the software produce?Output: A structured report containing the calculated CTR, adjustable annotation lines for the maximal transverse heart diameter and maximal inner transverse thoracic-cavity diameter, a compressed chest X-ray preview, and a trajectory of CTR records. Outputs are described in DICOM Secondary Capture and JSON formats; the trajectory is not predictive or prognostic.
  • What is its most important limitation?Key limitation: The output is not intended for standalone clinical decision-making and does not preclude clinical assessment. The labeled input is a PA chest X-ray for adults 20-80 years old; non-chest, non-PA, and unclear-boundary images are subject to quality-control filtering or messaging. The CTR trajectory does not implement a predictive or prognostic feature, and the packet does not establish a specific PACS, RIS, EHR, or current hosting configuration.

Clinical takeaway. Clinical role: Automatic cardiothoracic-ratio assessment on PA chest X-ray images for adults 20-80 years old in healthcare institutions; results support clinician assessment and are not for standalone clinical decision-making.

Evidence takeaway. Evidence from the reviewed source record: FDA clinical testing included at least 840 eligible PA chest radiograph images from adults 20-80 years old at three participating sites, 280 images per site. Agreement between iCTR-derived and physician-derived CTR was evaluated as accuracy, with an accuracy estimate of 0.95. Quality-control models reported sensitivity and accuracy of 0.99/0.99 for filtering non-chest X-rays and 0.99/0.97 for filtering non-PA chest X-rays; the two annotation models reported heart-diameter RMSE 8.81 mm and thoracic-cavity-diameter RMSE 14.3 mm. Imaging-mode and view identification accuracy estimates were greater than 95%.

Evidence context

Evidence context not reviewed for this FDA record.

Public-label constraints

Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.

Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.

Purpose
Automatic cardiothoracic-ratio assessment on PA chest X-ray images for adults 20-80 years old in healthcare institutions; results support clinician assessment and are not for standalone clinical decision-making.
  • Exact FDA submission
  • Checked 2026-09-08
Workflow role
Automated PA chest-radiograph quality control, heart and thoracic-cavity diameter annotation, CTR measurement, structured reporting, and non-predictive longitudinal CTR tracking for clinician review.
  • Exact FDA submission
  • Checked 2026-09-08
Required input
DICOM chest X-ray images in posterior-anterior (PA) view from adults 20-80 years old; quality-control models filter non-chest and non-PA images and present a message for images with unclear boundaries below the stated threshold.
  • Exact FDA submission
  • Checked 2026-09-08
Output and clinician action
A structured report containing the calculated CTR, adjustable annotation lines for the maximal transverse heart diameter and maximal inner transverse thoracic-cavity diameter, a compressed chest X-ray preview, and a trajectory of CTR records. Outputs are described in DICOM Secondary Capture and JSON formats; the trajectory is not predictive or prognostic.
  • Exact FDA submission
  • Checked 2026-09-08
Care setting
Clinics, hospitals, healthcare facilities, residential care facilities, and long-term care services
  • Exact FDA submission
  • Checked 2026-09-08
Intended users
Physicians or other licensed practitioners in healthcare institutions such as clinics, hospitals, healthcare facilities, residential care facilities, and long-term care services
  • Exact FDA submission
  • Checked 2026-09-08
Limitations
The output is not intended for standalone clinical decision-making and does not preclude clinical assessment. The labeled input is a PA chest X-ray for adults 20-80 years old; non-chest, non-PA, and unclear-boundary images are subject to quality-control filtering or messaging. The CTR trajectory does not implement a predictive or prognostic feature, and the packet does not establish a specific PACS, RIS, EHR, or current hosting configuration.
  • Exact FDA submission
  • Checked 2026-09-08
Evidence summary
FDA clinical testing included at least 840 eligible PA chest radiograph images from adults 20-80 years old at three participating sites, 280 images per site. Agreement between iCTR-derived and physician-derived CTR was evaluated as accuracy, with an accuracy estimate of 0.95. Quality-control models reported sensitivity and accuracy of 0.99/0.99 for filtering non-chest X-rays and 0.99/0.97 for filtering non-PA chest X-rays; the two annotation models reported heart-diameter RMSE 8.81 mm and thoracic-cavity-diameter RMSE 14.3 mm. Imaging-mode and view identification accuracy estimates were greater than 95%.
  • Exact FDA submission
  • Checked 2026-09-08

Evidence

Performance evidence

Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.

Evidence summary
FDA clinical testing included at least 840 eligible PA chest radiograph images from adults 20-80 years old at three participating sites, 280 images per site. Agreement between iCTR-derived and physician-derived CTR was evaluated as accuracy, with an accuracy estimate of 0.95. Quality-control models reported sensitivity and accuracy of 0.99/0.99 for filtering non-chest X-rays and 0.99/0.97 for filtering non-PA chest X-rays; the two annotation models reported heart-diameter RMSE 8.81 mm and thoracic-cavity-diameter RMSE 14.3 mm. Imaging-mode and view identification accuracy estimates were greater than 95%.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-08
Reported sensitivity
Research pending
  • Needs research
  • Exact FDA submission
  • Checked 2026-08-31

This field has not been curated yet.

Reported specificity
Research pending
  • Needs research
  • Exact FDA submission
  • Checked 2026-08-31

This field has not been curated yet.

No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.

EFAI Intelligent Cardiothoracic Ratio (iCTR) Assessment System regulatory performance study summary

  • DesignStand-Alone Performance
  • PopulationAdult
  • Scopeexact submission
  • Tested versionExact product version not reported; regulatory study summarized for FDA submission K212624
  • Samplen=840
  • IndependenceIndependence not established

K212624

ACR AI Central summarizes the regulatory study; consult the exact FDA materials before comparative use.

Safety and lifecycle

Postmarket record

Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.

Postmarket safety review
The exact-identifier FDA recall query returned no native recall record for K212624. This limited result does not establish absence of recalls or other safety information and does not cover later versions, family records, MAUDE reports, corrections, or field notices.
  • Public source
  • Exact FDA submission
  • Checked 2026-09-08
Pricing & contracts Public price, contract terms, and reimbursement

Price not public here; enter your quote

Not verified: Pricing information is recorded but not verified against a resolving source.

Reimbursement

IT implementation Deployment, interfaces, data handling, and support

System and version relationships

Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.

No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.

Review Merge, Visage, Sectra, AGFA and IntelePACS context

Integration chain: evidence at each hop

Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.

Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner

No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.

  1. Acquisition/source

    Source context, not route validation: DICOM chest X-ray images in posterior-anterior (PA) view from adults 20-80 years old; quality-control models filter non-chest and non-PA images and present a message for images with unclear boundaries below the stated threshold.

    Scope: Exact FDA submission.

    Confirm scanner/model, protocol, series completeness and both software builds.

    Field checked 2026-09-08 · FDA K212624: EFAI Intelligent Cardiothoracic Ratio (iCTR) Assessment System

  2. Routing

    Source context, not route validation: The packet describes a software device installed on a computer with specific system requirements, DICOM chest X-ray input, and DICOM/JSON or DICOM Secondary Capture report output; its comparison table lists Ubuntu 18.04 and a Chrome 88.0.4324.182-or-later browser context. A specific PACS, RIS, EHR, interface version, and current commercial deployment topology are not established.

    Scope: Exact FDA submission.

    Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.

    Field checked 2026-09-08 · FDA K212624: EFAI Intelligent Cardiothoracic Ratio (iCTR) Assessment System

  3. AI processing

    Source context, not route validation: The exact FDA package describes iCTR as a software medical device designed to be installed on a computer with specific system requirements, operating on off-the-shelf hardware. Current hosting, data flow, and commercial configuration require vendor confirmation.

    Scope: Exact FDA submission. Packet wording: "The iCTR is a non-invasive software medical device designed to be installed on the computer with specific system requirements." … "Software device that operates on off-the-shelf Yes Yes Same hardware". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.

    Confirm processing location, queue ownership, exclusions and exact AI build.

    Field checked 2026-11-14 · FDA K212624: EFAI Intelligent Cardiothoracic Ratio (iCTR) Assessment System

  4. Returned objects

    Source context, not route validation: A structured report containing the calculated CTR, adjustable annotation lines for the maximal transverse heart diameter and maximal inner transverse thoracic-cavity diameter, a compressed chest X-ray preview, and a trajectory of CTR records. Outputs are described in DICOM Secondary Capture and JSON formats; the trajectory is not predictive or prognostic.

    Scope: Exact FDA submission.

    Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.

    Field checked 2026-09-08 · FDA K212624: EFAI Intelligent Cardiothoracic Ratio (iCTR) Assessment System

  5. Viewer/worklist/report

    Unresolved route: A structured report containing the calculated CTR, adjustable annotation lines for the maximal transverse heart diameter and maximal inner transverse thoracic-cavity diameter, a compressed chest X-ray preview, and a trajectory of CTR records. Outputs are described in DICOM Secondary Capture and JSON formats; the trajectory is not predictive or prognostic.

    Scope: Exact FDA submission.

    Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.

    Field checked 2026-09-08 · FDA K212624: EFAI Intelligent Cardiothoracic Ratio (iCTR) Assessment System

  6. Support owner

    Unresolved route: Not established for the exact route.

    Scope: Scope not established.

    Name the local, platform and AI supplier support owners and escalation path.

Planned local route tests

No tests below have been performed or accepted.

  1. Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
  2. Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
  3. Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
  4. Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
  5. Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
  6. Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
  7. Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.

Local implementation checklist

Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.

Open the printable evaluation checklist

Deployment
The exact FDA package describes iCTR as a software medical device designed to be installed on a computer with specific system requirements, operating on off-the-shelf hardware. Current hosting, data flow, and commercial configuration require vendor confirmation.
  • Exact FDA submission
  • Checked 2026-11-14

Packet wording: "The iCTR is a non-invasive software medical device designed to be installed on the computer with specific system requirements." … "Software device that operates on off-the-shelf Yes Yes Same hardware". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.

Integration
The packet describes a software device installed on a computer with specific system requirements, DICOM chest X-ray input, and DICOM/JSON or DICOM Secondary Capture report output; its comparison table lists Ubuntu 18.04 and a Chrome 88.0.4324.182-or-later browser context. A specific PACS, RIS, EHR, interface version, and current commercial deployment topology are not established.
  • Exact FDA submission
  • Checked 2026-09-08
Security
Ever Fortune.AI's investor information-security policy page states an implemented information security management system covering confidentiality, integrity, and availability, with security training and measurement targets; the page states the company has completed ISO 27001 certification and holds ISO/IEC 27701 PII-processor certification after independent third-party audit. The company's certification-milestones page lists ISO/IEC 27001:2022, ISO 22301:2019, ISO/IEC 27018:2019, and ISO/IEC 27017:2015.
  • Vendor-wide
  • Checked 2026-10-27

Vendor statement; certificates were not read. Applicant name variants (including uppercase and punctuation variants of Ever Fortune.AI Co., Ltd.) are bridged via the vendor's EFAI product naming and the owning domain everfortuneai.com.tw. Exact-release scope is not established.

Input or output interoperability

DICOM is explicitly referenced in the described input, output, or workflow.

exact submission · checked 2026-09-01

The model card does not establish every supported DICOM object, transfer method, or local interface.

ACR exact-submission catalog context

ACR AI Central provides an exact-submission model card for EFAI Intelligent Cardiothoracic Ratio (iCTR) Assessment System; FDA labeling remains controlling for clinical use, limitations, and performance.

exact submission · checked 2026-09-08
Sources & review details FDA identity, research record, source ledger, and history

Regulatory identity

FDA record and catalog context

The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.

FDA submission
K212624
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Modality
X-ray/Radiography
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-08
Anatomy
Heart and thoracic cavity for cardiothoracic-ratio measurement
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-08
Clearance type
510(k)
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Decision date
2022-04-04
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
FDA status
FDA-cleared
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31

Research record

What has been checked

This audit distinguishes completed source review from fields that have not yet been researched.

Exact FDA record reviewedStatus
2026-09-20Last searched
22Fields reviewed
9Source classes checked
0Screened PubMed leads
0Screened trial leads
0Unreviewed FDA recall leads

The refreshed discovery snapshot contains no PubMed or ClinicalTrials.gov candidates; no external evidence was promoted. The current discovery snapshot contains 0 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.

Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.

Source classes: fda ai list, fda decision summary, acr ai central product, fda device recall, literature index, trial registry, pubmed, clinical trials, openfda device recall

Field review details

Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.

  • Public pricing: Not verified - checked 2026-09-08 - Exact FDA submission

    No public price or quote for the exact K212624 configuration was established in this review.

  • Pricing model: Not yet reviewed
  • Setup and integration fees: Not yet reviewed
  • Recurring fees: Not yet reviewed
  • Minimum commitment: Not yet reviewed
  • Contract duration: Not yet reviewed
  • Renewal terms: Not yet reviewed
  • Cancellation terms: Not yet reviewed
  • Support and service terms: Not yet reviewed
  • Trial or pilot terms: Not yet reviewed
  • Reimbursement: Not publicly available - checked 2026-09-08 - Exact FDA submission

    No exact-product payer policy, coding instruction, or payment determination was established; eligibility must be evaluated by payer, site of service, and use case.

  • Data hosting location: Not yet reviewed
  • Data retention: Not yet reviewed
  • Documented data use: Not yet reviewed
  • Hardware requirements: Not yet reviewed
  • Network requirements: Not yet reviewed
  • Identity and access: Not yet reviewed
  • Installation timeline: Not yet reviewed
  • Training: Not verified - checked 2026-09-08 - Exact FDA submission

    Current training prerequisites, competency checks, and support commitments for the exact configuration require vendor confirmation.

  • Monitoring: Not verified - checked 2026-09-08 - Exact FDA submission

    Current drift, quality, uptime, alert, escalation, and incident-response commitments for the exact configuration require vendor confirmation.

8 sources - 3 history items

Source ledger

  1. FDA K212624: EFAI Intelligent Cardiothoracic Ratio (iCTR) Assessment System

    U.S. Food and Drug Administration - Published 2022-04-04 - Accessed 2026-09-08

    Scope: identity, clinicalUse, modality, anatomy, workflow, evidence, implementation, deployment

  2. Artificial Intelligence-Enabled Medical Devices

    U.S. Food and Drug Administration - Accessed 2026-08-31

    Scope: regulatoryIdentity, modalityContext

  3. EFAI Intelligent Cardiothoracic Ratio (iCTR) Assessment System model card (K212624)

    American College of Radiology - Published 2026-08-17 - Accessed 2026-09-01

    Scope: intendedUsers, careSetting, output, evidenceSummary, integration, anatomy, evidenceStudies, implementationCapabilities

  4. PubMed biomedical literature index

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery

  5. ClinicalTrials.gov study registry

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery, studyStatus

  6. openFDA Device Recall API

    U.S. Food and Drug Administration - Accessed 2026-09-02

    Scope: recallDiscovery, nativeSubmissionMatching

  7. openFDA exact recall query for K212624

    U.S. Food and Drug Administration - Accessed 2026-09-08

    Scope: postmarketSafety

  8. Ever Fortune.AI: Information Security Policy (ISO 27001 / ISO 27701)

    Ever Fortune.AI - Accessed 2026-10-27

    Scope: security

Research history

  1. K212624 FDA decision

    Regulatory record

    510(k)

  2. Source-review record updated

    Research record

    fda record reviewed

  3. Reader overview source-reviewed

    Editorial review

    Source-reviewed editorial overlay

Alternatives

Related tools to compare

FDA-cleared K231149

qXR-CTR

Qure.ai Technologies

Authorized purpose: Automated measurement of cardiac diameter, thoracic diameter, and the cardiothoracic ratio (CTR) on posterior-anterior chest X-rays to aid physicians or licensed practitioners; not a stand-alone decision tool.

Modality
X-ray/Radiography
Anatomy
Heart and thoracic cavity
Decision
2023-09-22
FDA-cleared K222036

MPXA-2000

Medipixel, Inc.

Authorized purpose: Quantified results from X-ray angiographic images of the coronary arteries to support clinical decisions about diagnosis or treatment evaluation in adult patients with coronary artery disease; results are not the sole basis for diagnosis.

Modality
X-ray/Radiography
Anatomy
Coronary arteries and cardiovascular anatomy
Decision
2023-03-22
FDA-cleared K251934

qXR-Detect

Qure.Ai Technologies

Authorized purpose: qXR-Detect is an adult chest-radiograph concurrent reading aid that identifies, highlights and categorizes suspicious regions of interest across lung, pleura, mediastinum/hila/heart, bone, hardware and other categories; trained clinicians remain responsible for primary interpretation.

Modality
X-ray/Radiography
Anatomy
Chest/Lung; pleura, mediastinum/hila/heart, bone, hardware and other chest-radiograph regions
Decision
2026-01-16
FDA-cleared K250914

MediAI-BA

Crescom Co., Ltd.

Authorized purpose: View and quantify bone age from 2D posteroanterior left-hand radiographs to aid pediatric radiologists assessing patients aged 2-18 years.

Modality
X-ray/Radiography
Anatomy
Left hand and wrist; skeletal maturity/bone age
Decision
2025-12-18

Correct this exact record

Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.

Open existing correction destination

Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.

Accepted repository change history

No entry has been added to this scoped change history for this record. This is not proof that the record never changed.

Correction policy and limits · Public repository change history